|
| N | % |
| Year of diagnosis |
|
|
| 2019 | 42 | 26.3 |
| 2020 | 72 | 45.0 |
| 2021 | 46 | 28.7 |
| Time of onset of symptoms and first visit to the doctor |
|
|
| One month | 66 | 41.3 |
| 3 months | 14 | 8.8 |
| >3 months | 17 | 10.6 |
| Randomly | 28 | 17.5 |
| Not given | 35 | 21.9 |
| Treatment |
|
|
| Chemotherapy | 57 | 35.6 |
| Immunotherapy | 40 | 25.0 |
| Chemotherapy/Immunotherapy | 26 | 16.3 |
| Chemotherapy/radiotherapy | 18 | 11.3 |
| Chemotherapy/radiotherapy/immunotherapy | 11 | 6.9 |
| Radiotherapy/immunotherapy | 8 | 5.0 |
| Radiotherapy/immunotherapy |
|
|
| Commorbidity |
|
|
| Yes | 73 | 45.6 |
| No | 87 | 54.4 |
| COVID-19 infection |
|
|
| Yes | 11 | 6.9 |
| No | 149 | 93.1 |
| COVID-19 infection of family members |
|
|
| Yes | 19 | 11.9 |
| No | 141 | 88.1 |